title: Pulmonary hypertension therapy and COPD: still many questions to be answered.
authors.forename: V
authors.initials: V
authors.lastname: Cottin
authors.forename: C
authors.initials: C
authors.lastname: Khouatra
authors.forename: R
authors.initials: R
authors.lastname: Lazor
authors.forename: P
authors.initials: P
authors.lastname: Canu
authors.forename: J-F
authors.initials: JF
authors.lastname: Cordier
mesh_terms: D000959:Antihypertensive Agents / Q000494:pharmacology; D000077300:Bosentan; D006801:Humans; D006976:Hypertension, Pulmonary / Q000150:complications* / Q000188:drug therapy*; D008168:Lung / Q000187:drug effects; D011651:Pulmonary Artery / Q000473:pathology; D029424:Pulmonary Disease, Chronic Obstructive / Q000150:complications* / Q000473:pathology; D012107:Research Design; D013449:Sulfonamides / Q000494:pharmacology; D016896:Treatment Outcome
chemical_list: D000959:Antihypertensive Agents; D013449:Sulfonamides; D000077300:Bosentan